Skip to main content
Erenumab demonstrates more favorable efficacy than rimegepant for migraine prevention
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Erenumab demonstrates more favorable efficacy than rimegepant for migraine prevention
User login
Username
Password
Reset your password
Concept
Lead
score
Migraine
1
1
Monoclonal Antibody
0
0.95
Comparative Effectiveness
0
0.85
Quality of Life
0
0.75
Specialty
Lead
score
Neurology & Neurosurgery
1
1
Family Medicine/Primary Care
0
0.99
Edit Tags